Weekly Research Analysts’ Ratings Changes for CVS Health (CVS)

Several analysts have recently updated their ratings and price targets for CVS Health (NYSE: CVS):

• 9/9/2026 – CVS Health was given a new $112.00 price target by BMO Capital Markets.
• 9/9/2026 – CVS Health was given a new $112.00 price target by Piper Sandler.
• 9/9/2026 – CVS Health had its “outperform” rating reaffirmed by Sanford C. Bernstein. They now have a $112.00 price target on the stock.
• 9/3/2026 – CVS Health had its price target lowered by UBS Group AG from $126.00 to $118.00. They now have a “buy” rating on the stock.
• 8/26/2026 – CVS Health had its “overweight” rating reaffirmed by Piper Sandler.
• 8/19/2026 – CVS Health had its price target raised by Argus from $104.00 to $114.00. They now have a “buy” rating on the stock.
• 8/12/2026 – CVS Health had its price target raised by JPMorgan Chase & Co. from $111.00 to $118.00. They now have an “overweight” rating on the stock.
• 8/8/2026 – CVS Health was upgraded by Wall Street Zen from “buy” to “strong-buy”.
• 8/6/2026 – CVS Health was given a new $107.00 price target by Robert W. Baird.
• 8/6/2026 – CVS Health had its price target raised by UBS Group AG from $122.00 to $126.00. They now have a “buy” rating on the stock.
• 8/6/2026 – CVS Health had its price target raised by Barclays PLC from $106.00 to $108.00. They now have an “overweight” rating on the stock.
• 8/5/2026 – CVS Health was upgraded by Weiss Ratings from “hold (c+)” to “buy (b-)”.
• 7/24/2026 – CVS Health had its price target raised by UBS Group AG from $115.00 to $122.00. They now have a “buy” rating on the stock.
• 7/23/2026 – CVS Health was upgraded by Wall Street Zen from “hold” to “buy”.
• 7/20/2026 – CVS Health was upgraded by Weiss Ratings from “hold (c)” to “hold (c+)”.
• 7/15/2026 – CVS Health was downgraded by Wall Street Zen from “buy” to “hold”.
• 7/14/2026 – CVS Health had its price target raised by Truist Financial Corporation from $108.00 to $118.00. They now have a “buy” rating on the stock.
• 7/13/2026 – CVS Health had its price target raised by Wells Fargo & Company from $103.00 to $123.00. They now have an “overweight” rating on the stock.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 2.8%. The ex-dividend date of this dividend was Thursday, July 23rd. CVS Health’s payout ratio is 70.37%.

CVS Health Corporation is an American health care company headquartered in Woonsocket, Rhode Island. Founded in 1963 as Consumer Value Stores, the company has expanded from a chain of retail pharmacies into an integrated health care organization serving consumers, employers, health plans, government programs and health care providers.

CVS Health operates through several major businesses. Its Health Care Benefits segment, anchored by Aetna, provides health insurance products and related services for employers, individuals, Medicare and Medicaid members.